Epstein-Barr Virus-Positive Large Cell Neuroendocrine Carcinoma of the Nasopharynx: Report of a Case with Complete Clinical and Radiological Response After Combined Chemoradiotherapy

Head and Neck Pathology - Tập 12 Số 4 - Trang 587-591 - 2018
Jason K. Wasserman1, Sylvia Papp1, Andrew Hope1, Bayardo Perez-Ordóñez2
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
2Laboratory Medicine Program, Department of Pathology, University Health Network, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. IARC: Lyon; 2017.

Kraft S, Faquin WC, Krane JF. HPV-associated Neuroendocrine Carcinoma of the Oropharynx. Am J Surg Pathol. 2012;36:321–30.

Bates T, Mcqueen A, Iqbal MS, Kelly C, Robinson M. Small cell neuroendocrine carcinoma of the oropharynx harbouring oncogenic HPV-infection. Head Neck Pathol. 2013;8:127–31.

Chua MLK, Wee JTS, Hui EP, Chan ATC. Nasopharyngeal carcinoma. Lancet. 2016;387:1012–24.

Kao H-L, Chang W-C, Li W-Y, Li AC-H, Li AF-Y. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis. Am J Surg Pathol. 2012;36:185–92.

Travis WD. Pathology and diagnosis of neuroendocrine tumors. Thorac Surg Clin. 2014;24:257–66.

Elloumi F, Fourati N, Siala W, Ghorbell L, Jlidi R, Ghorbel A, et al. Tumeur neuroendocrine à grandes cellules du nasopharynx: à propos d’un cas. Cancer/Radiothérapie. 2014;18:208–10.

Sturgis CD, Burkey BB, Momin S, Hoschar AP. High grade (large cell) neuroendocrine carcinoma of the nasopharynx: novel case report with touch preparation cytology and positive EBV encoded early RNA. Case Rep Pathol. 2015;2015:1–4.

Dumars C, Thebaud E, Joubert M, Renaudin K, Cariou-Patron G, Heymann M-F. Large cell neuroendocrine carcinoma of the nasopharynx. J Pediatric Hematol/Oncol. 2015;37:474–6.

Petersson F. Nasopharyngeal carcinoma: a review. Semin Diagn Pathol. 2015;32:54–73.

Iyoda A, Makino T, Koezuka S, Otsuka H, Hata Y. Treatment options for patients with large cell neuroendocrine carcinoma of the lung. General Thorac Cardiovasc Surg. 2014;62:351–6.

Iyoda A, Hiroshima K, Moriya Y, Takiguchi Y, Sekine Y, Shibuya K, et al. Prospective Study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Ann Thorac Surg. 2006;82:1802–7.

Sarkaria IS, Iyoda A, Roh MS, Sica G, Kuk D, Sima CS, et al. Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience. Ann Thorac Surg. 2011;92:1180–7.

Laan TPVD, Plaat BEC, Laan BFVD, Halmos GB. Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: a meta-analysis of 436 reported cases. Head Neck. 2014;37:707–15.

Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015;33:3356–64.

Gao W, Li Z-H, Chen S, Chan JY-W, Yin M, Zhang M-J, et al. Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma. Oncotarget. 2017;8:20297.

Dworakowska D, Grossman AB. Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review. Endocr Relat Cancer. 2009;16:45–58.